Sessa Capital IM, L.P. — SEC Form 4 filings

SEC reporting owner CIK 1595849. 3 Form 4 filings on record with FilingPulse; latest filed 2025-10-01.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-03-06 to 2025-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Garrett Motion Inc. (GTX)10% owner11 leg · 10,000,000 sh · $90,000,000
SAB Biotherapeutics, Inc. (SABS)Director25

Form 4 filings — Sessa Capital IM, L.P.

FiledFormIssuerReported transactionsSource
2025-10-014SAB Biotherapeutics, Inc. (SABS)
jointly with Sessa Capital (Master), L.P., Sessa Capital GP, LLC, Sessa Capital IM GP, LLC, Petry John
Option exercise (M): 1,740,000 @ $1.75 · Option exercise (M): 17,400 (derivative)EDGAR
2025-07-244SAB Biotherapeutics, Inc. (SABS)
jointly with Sessa Capital (Master), L.P., Sessa Capital GP, LLC, Sessa Capital IM GP, LLC, Petry John
Grant/award (A): 228,500 (derivative) · Grant/award (A): 228,500 (derivative) · Grant/award (A): 114,250 (derivative)EDGAR
2024-03-064Garrett Motion Inc. (GTX)
jointly with Sessa Capital GP, LLC, Sessa Capital (Master), L.P., Sessa Capital IM GP, LLC, Petry John
Sale (S): 10,000,000 @ $9EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1595849 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →